References Acute Myeloid Leukemia (AML) in Children and Teens - Together . (n.d.). Retrieved October 23, 2022, from https://together.stjude.org/en-us/about-pediatric-cancer/types/leukemia/acute-myeloid-leukemia-aml.html Chen, K. T. J., Gilabert -Oriol, R., Bally, M. B., & Leung, A. W. Y. (2019). Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia . Pharmaceutical Research , 36 (9). https://doi.org/10.1007/S11095-019-2654-Z Chen, Y., Chen, S., Lu, J., Yuan, D., He, L., Qin, P., Tan, H., & Xu, L. (2021). MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B. Medicine , 100 (18), e25807. https://doi.org/10.1097/MD.0000000000025807 Collins, C. T., & Hess, J. L. (2016). Role of HOXA9 in leukemia : dysregulation, cofactors and essential targets. Oncogene , 35 (9), 1090. https://doi.org/10.1038/ONC.2015.174 Esa , E., Hashim, A. K., Mohamed, E. H. M., Zakaria, Z., Abu Hassan, A. N., Mat Yusoff , Y., Kamaluddin , N. R., Abdul Rahman, A. Z., Chang, K. M., Mohamed, R., Subbiah, I., Jamian , E., Ho, C. S. L., Lim, S. M., Lau, P. C., Pung , Y. F., & Zain, S. M. (2021). Construction of a microRNA-mRNA Regulatory Network in de Novo Cytogenetically Normal Acute Myeloid Leukemia Patients. Genetic Testing and Molecular Biomarkers , 25 (3), 199–210. https://doi.org/10.1089/gtmb.2020.0182 23